Showing 2721-2730 of 3392 results for "".
- Miramar Labs to Launch miraSmooth Treatment with FDA Clearance of miraDry For Permanent Reduction of Underarm Hairhttps://practicaldermatology.com/news/miramar-labs-to-launch-mirasmooth-treatment-with-fda-clearance-of-miradry-for-permanent-reduction-of-underarm-hair/2458906/Miramar Labs’ miraDry® System received FDA clearance for the treatment of unwanted underarm hair, and permanent reduction of underarm hair of all colors. Miramar Lab's proprietary miraWave® technology—use of precisely controlled microwave energy—is the founda
- LEO Pharma Inc. Announces New Vice President of Saleshttps://practicaldermatology.com/news/leo-pharma-inc-announces-new-vice-president-of-sales/2458915/Mitchell Johnson has joined the LEO U.S. Region as Vice President of Sales. "Mitch is a welcomed addition to our team. He is an energetic sales leader and strategist with proven results in the pharmaceutical industry," stated Barbara Osborne, President & CEO, LEO U.S. Mr. Jo
- AMBI Now Part of Valeant Pharmaceuticalshttps://practicaldermatology.com/news/20121221-ambi_now_part_of_valeant_pharmaceuticals/2459653/Johnson & Johnson has sold the AMBI brand to Valeant Pharmaceuticals North America. Valeant is a multinational, pharmaceutical/OTC company based in Bridgewater, NJ.
- John Dobak, MDhttps://practicaldermatology.com/profiles/john-dobak-md/7ZKVmk/
- John Browning, MDhttps://practicaldermatology.com/profiles/john-browning-md/Lbxl1E/
- John E. Harris, MD, PhDhttps://practicaldermatology.com/profiles/john-e-harris-md-phd/jMw3Dr/
- John E. Harris, MD, PhDhttps://practicaldermatology.com/profiles/john-e-harris-md-phd/LgvgWV/
- John Josephhttps://practicaldermatology.com/profiles/john-joseph/L6KmYX/
- John Almansbergerhttps://practicaldermatology.com/profiles/john-almansberger/L2WoyJ/
- Patrick Burnett, MD, PhD, FAADhttps://practicaldermatology.com/profiles/patrick-burnett-md-phd-faad/OBAr9b/Patrick Burnett has served as Arcutis’ chief medical officer since August 2020. Prior to that, Dr Burnett was the chief medical officer at Verrica Pharmaceuticals since April 2018. Prior to that, Dr Burnett was at Sun Pharmaceuticals where he was associate vice president of clinical development fro…